MCOLN2 and glioma: These results indicate that higher expression of TRPC1 and TRPC3 correlates with a better prognosis in patients with glioma, while higher expression of TRPC6, MCOLN1, MCOLN2, and MCOLN3 correlates with a worse prognosis in patients with glioma.